Tag: Cancer: Cervical
Less Frequent Cervical CA Screens May Be OK After HPV Vaccine
Less testing could reduce risk of false-positives and save money, researchers say
Ovarian Preservation Doesn’t Impact Prognosis in Cervical CA
Risk factors for metastases include stage IIB, cervical stromal invasion, lymph node metastasis
Low Incidence of Cervical Cancer, CIN3+ for HPV-Negative Women
Low incidence may support extension of cervical screening interval beyond five years
More Evidence HPV Vaccine Protects Against Cervical Cancer
Protection appears to occur even when only one or two of the recommended doses are given
ASTRO: Fewer Side Effects With IMRT in Cervical, Endometrial CA
Patients in conventional radiotherapy arm had more high-level adverse events than those in IMRT arm
Approval of First HPV Test for Use With SurePath Preservative Fluid
For cervical cells obtained for Pap test, collected in SurePath Preservative Fluid
CDC: Majority of HPV-Linked Cancers Are Preventable
Cervical cancer, and oropharyngeal cancers in men, account for most HPV-associated cancers
ASCO Develops Recommendations for Invasive Cervical Cancer Care
Most effective evidence-based antitumor and palliative care interventions should be provided
Substantial Aggregate Costs of Care for Cervical Cancer
Advanced age, stage at diagnosis, comorbidities predict greater costs in most care phases
HIV-Seropositive CIN3+ Patients Have Lower HPV16 Prevalence
HIV-seropositive women have lower HPV-16, higher non-alpha-9 oncHPV prevalence
